Compare PHAR & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHAR | HBT |
|---|---|---|
| Founded | 1988 | 1920 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2020 | 2019 |
| Metric | PHAR | HBT |
|---|---|---|
| Price | $12.94 | $36.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $38.33 | $30.75 |
| AVG Volume (30 Days) | 4.5K | ★ 133.8K |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.29% |
| EPS Growth | N/A | ★ 7.96 |
| EPS | N/A | ★ 0.34 |
| Revenue | N/A | N/A |
| Revenue This Year | $10.04 | $35.73 |
| Revenue Next Year | $2.51 | $7.01 |
| P/E Ratio | $3,041.22 | ★ $106.69 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.55 | $22.36 |
| 52 Week High | $21.34 | $36.45 |
| Indicator | PHAR | HBT |
|---|---|---|
| Relative Strength Index (RSI) | 38.08 | 78.61 |
| Support Level | $11.88 | $27.07 |
| Resistance Level | $13.61 | N/A |
| Average True Range (ATR) | 0.46 | 0.94 |
| MACD | -0.11 | 0.31 |
| Stochastic Oscillator | 3.92 | 96.07 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking. It generates revenue from Card income, Wealth management fees, and Service charges on deposit accounts.